{"name":"Fondazione Telethon","slug":"fondazione-telethon","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNeEJlNms4UnJKZHk2cDhsaTNlMWN0R2VOMXZQSjM5UWFYVzl6aDJuT3NpQlYzR0RSNWlVamNyaGhUSVBVR1d4bEdpdzh0cTRzVUpoVnduWE5TNlJDdkJPa0R4RlRlQU4xS0RTWVN6WlM1Y3BZUi1BWFRJZnFuV1dUX3ZVajhLb043ZTdwMVdWWl9BOVcwUjZtMnhKRUJrMHU1NDJvMg?oc=5","date":"2026-01-16","type":"pipeline","source":"The Pharma Letter","summary":"EC authorization for Waskyra for Wiskott-Aldrich syndrome - The Pharma Letter","headline":"EC authorization for Waskyra for Wiskott-Aldrich syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOajBuaE9vVjhndVdOeGZrVzJ2NXNFNFdmVGp3MUdiRjN1VmllU1lBbUtyR2RicFBxWEJKOTF4Umd5c1FnSDBsQzZwWXZfVlFFc29CUzZsUTJydDQ2UWFhclJENVRPaWRFYXo2OGo3WkpVN3BxZ3RENkhZOFRfTFh1MERZYUxpRkFoTFlmWk5TUldaVm51eWppRWtvZ0VDbHpjcHlSS0dyS1dWcUJYc3VJSFZOQ0tnelFDV1pn?oc=5","date":"2025-12-16","type":"pipeline","source":"The Medicine Maker","summary":"This Week’s Biopharma News: New Pharma Legislation in Europe - The Medicine Maker","headline":"This Week’s Biopharma News: New Pharma Legislation in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNRnNXRDh6VHZOQXNMNGY1Rnd2QWE0VzJEMmRCNENES1dJazZtcTR0SE5CajR2czc0QXY5Y2VSVm5NWkhfaVBCYk1JS0RBM2Q4LWkxVUh2dTBSSUZvZi1yMmZMTE9rNWlmRkVyQTlCVC1taWFYUjNxTS1zejJNTWo3YjZRTnFjd3V6czhsRFhGaENwVmw4STFDTGFvblFIdGNNZFVzblY5NXJaRWJtcnhGOE51Z3kwcGJrdGpUTnVfd0c?oc=5","date":"2025-12-10","type":"regulatory","source":"Fierce Pharma","summary":"Italian nonprofit lands FDA approval for 1st gene therapy to treat rare genetic disease - Fierce Pharma","headline":"Italian nonprofit lands FDA approval for 1st gene therapy to treat rare genetic disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNQ2VpejNaYXVJTGl5YkJkUjEtd1FrX18tSHBYSEZfcW9xVFRxcW9MbGVTQ3d5YXlSWEJuVlpJZWY2R054RUdjN2VlUTFacnZyS3RCTlpUWDRHVFQ2MHZnZTF5VTBGUFhoVGRyUlNMdWlUQ0YtTloybTZFZF9yckdzaDNDWVg1OG5zR2x4UA?oc=5","date":"2025-12-10","type":"regulatory","source":"pharmaphorum","summary":"FDA clears first gene therapy for rare genetic disease WAS - pharmaphorum","headline":"FDA clears first gene therapy for rare genetic disease WAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOaHZQd0FMMU94bWtUYVZycWlBalNIMWZFSGxfUXFpenJQY3NZbnlOQVB5Q1lpbWEyZDA1d1VmOXBmREg3bkdWNFgyX3NBNEJKUzBaMjZ0OGhuTnJ6QjlJTTU1X044WGw1Umh0c3IxQm5HZ3JJMGxwZTg5N2RjYW14eHdxN3l2YUlZTzZMVDVnZVdIdFZkQkNEcmU3VFJxX19GdHRraDd0bWpySTRibkc2UDhrSk1sZ2c2TUFVSmppSTN2QQ?oc=5","date":"2025-12-10","type":"regulatory","source":"MedCity News","summary":"FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder - MedCity News","headline":"FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTTJJUWZvRHN3Qk1BVDNKYUpidTM3ZS15U2xQbk9EWDZLYVBhRVV2Y3Fpb2tTZUlpR3JNNmZlaWtxMkE2aVI1elRSbkV3dDR4WVhkR1ZOQlU4NUVmc0MyalJULTcwdE5DWm9CYmFBS3plM2ROTVphVzBtYS13N0h5dGl4OGJZb0xGUUxhYURrYTFjc184LVQxalE2ckk4VU5NX1FZV1EyN0hhanU5VEtCUXBLeFpOc05jTGU2Ym42ZzB1Zw?oc=5","date":"2025-12-09","type":"regulatory","source":"Reuters","summary":"FDA approves first gene therapy for rare immune disorder - Reuters","headline":"FDA approves first gene therapy for rare immune disorder","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2LUJiTDN1NmZFY2NqMVVYZjJ6QnExb2t3M21FUVE1V1dIenVHbVNkMXdESjQzeFNaMTk2U3djRm5XUUViTG5zUEtUU2g3a3dIZ2lJ?oc=5","date":"2025-12-09","type":"regulatory","source":"FirstWord Pharma","summary":"FDA approves first gene therapy for rare immunodeficiency disorder - FirstWord Pharma","headline":"FDA approves first gene therapy for rare immunodeficiency disorder","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQRVdMSG1EMUNkSFNSOUoxNk5wU2RXZlpKTGxHb0R1cUUyUjhwT1dQc0pMMzc3WnRaaThaWVluQ0lnYzAybG5pV1lxZkF4TlJrTVVwaUswb0pUWVZNZ29JZ1dEUEUxd1R4bGl4R3NxZFhtdS03WGVGOVJxN05xSEs3ZlVGNjREQjNITEZKbHhWOTZGTXViNURQek85N3dudHpCZlQ0?oc=5","date":"2025-11-14","type":"pipeline","source":"BioWorld News","summary":"Charity bringing to EU market gene therapy spurned by pharma - BioWorld News","headline":"Charity bringing to EU market gene therapy spurned by pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOU1BqaVJhWURFbTAtc1FMelRMQTg1WnJ4QzNKYVNXSnVNRFJGeW1zUDRzWWhZU0pxa0ZOajFwZTFXaVBXa0FZUDVVRHY5WFZxT2JpVEM1d1JULUQyQ2NsQzFscjhya3h0WFU0eFd0VzRlNlUxN084bmhFRjFSMlh2SGtwR285SXU1Q3pxX29qcFRPR2hnMnFmY1BLUk9OTnZfUFNvU3ZzaGN4V1JLS1UxejZ4THFmaU5Id0ZmM2NuT1BQODZiOHdualVDclhCdThhVU9V?oc=5","date":"2025-11-14","type":"regulatory","source":"News-Medical","summary":"Fondazione Telethon achieves milestone with Waskyra approval for Wiskott-Aldrich Syndrome - News-Medical","headline":"Fondazione Telethon achieves milestone with Waskyra approval for Wiskott-Aldrich Syndrome - News","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1M05IVlZQMTVTTTlHYmptTXhibGdDeGdOYzVIbUtYN0xfSzBKMElmbGpPcER0R1pDdFRJV3BxVEpJRHJ4VGJPcUpvTTVBR2hKZnNJa0NyWkE4Vl9z?oc=5","date":"2025-10-07","type":"pipeline","source":"EurekAlert!","summary":"In vivo gene therapy: lentiviral vectors into the spotlight - EurekAlert!","headline":"In vivo gene therapy: lentiviral vectors into the spotlight - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxPSy1ibklmY1JvSHNkOElKRnJVeEpzSUxFMTVnNzlQRlEtS2wyRXcyMWVkWkM2MVRERGhmUkJNaXVFQTR6MmtsS0tDZUczYmZEQ2xqNWlwQzI0SGlaQ3FiWGJPbUJxanlDWjQ1YW94bm93WnIwWlE0STJQOEI4VDZpZTJOZ2tFa05GNHNSNjBiLWZRNE1tWmkzcVJPdmJPTl9CV1JqcnEwejhLdXBGMy1odTN1dnpINjdsN1l0WnJ5WUt2TkVzcFJFZFlkVV9welVUeWVJSTA0enZtX01WcnUwRGxNQW9hOWRyM3RLVmJKcDJvWl9hamhYRnVqUWFYVjI1QUdreGxyRlNfbXVMM3Zxb0ctYkVNeE02YVFjTm85bDd5VWxzQ3lUY1l6M2l2ckNGY0c5Y1FJTGh5SFlJRlZvTnR4MDJZcERvNDVwdUFUbmNWSGljNy13aVlvNA?oc=5","date":"2025-03-11","type":"regulatory","source":"Ricerca Malattie Genetiche Rare","summary":"BLA for the gene therapy for the treatment of Wiskott-Aldrich syndrome submitted to FDA - Ricerca Malattie Genetiche Rare","headline":"BLA for the gene therapy for the treatment of Wiskott-Aldrich syndrome submitted to FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNb3RtMHZPQnFIM3FrTnpWaTE1akhaY2gwaUtNYTIydWxxQWVrM2hNNlFOY3ZQOGdYM3ptdURzV3lSWGVpaUVwOEp5bXFsNk9oWHF5LXp5djJySko4alpZd1NOYmhhVmRjVkR6ZkppYkl1dEU1Tnl3bldFNEF4TEY2b19NUzRuR1JqRkxlNUNnMG44WnNGUnR3dmRJeUhrdXd6b1RJWm5UQi1JT2lOYlZSRUlLQ2hUaVJzaF9KNFBaRXcyd29PbUtyLW8zMF85MHFNYmU1Wk9pMEM2UjVFcGx2V0Q5U2lKeDJ4RURnaEJET2thY2I3ZDNmZVdPZngxZlJBb2trSk54NlBpZFcwOVZkQ1l3MnpES1F6N0NHSHBHSFFxbjQ?oc=5","date":"2024-02-28","type":"pipeline","source":"Ricerca Malattie Genetiche Rare","summary":"Fondazione Telethon announces commitment to make gene therapy for Wikott-Aldrich Syndrome available to patients - Ricerca Malattie Genetiche Rare","headline":"Fondazione Telethon announces commitment to make gene therapy for Wikott-Aldrich Syndrome available to patients","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}